The clinical laboratory industry knows all too well the legal hazards posed by the federal False Claims Act (FCA). Throughout the 1990s in particular, the government wielded the Act to wring multimillion-dollar settlements from large labs nationwide to resolve allegations of fraudulently billing Medicare and Medicaid for medically unnecessary testing.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

January 15, 2007 - Table of Contents

NIR January 15, 2007 (full PDF issue)

Medicare Fee Fix Tops Physicians’ Legislative Agenda

Claims Will Be Paid at Correct ’07 Rates, CMS Assures Doctors

FDA Okays New Blood Screening Test for Chagas Disease

Pathology RVU Changes = Lower PC Rates, Some TC Gains

Key Laboratory, Pathology Priorities for the New Congress

States Get Financial Incentive to Beef Up False Claim Laws

CMS Rescinds Notice Ending Pathology TC Protection

Down Syndrome Screening Urged for All Pregnancies

Washington Watch: On a Personal Note